Ignite Creation Date:
2024-05-06 @ 6:50 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05808023
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2023-03-15
Brief Title:
Dose-dependent FODMAP Reintroduction in IBS
Sponsor:
Universitaire Ziekenhuizen KU Leuven
Organization:
Universitaire Ziekenhuizen KU Leuven
Study Overview
Official Title:
Dose-dependent Individual FODMAPs Mannitol and Fructans Reintroduction in Patients With Irritable Bowel Syndrome
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DORI
Brief Summary:
The aim of this study is to evaluate whether symptom recurrence after successful FODMAP elimination is dose-dependent in patients with IBS The effect of a blinded reintroduction of FODMAP powders fructans and mannitol will be investigated in a crossover dose-escalation scheme for the identification of the eliciting dose in individual patients The reintroduction of FODMAPs is performed after a successful elimination by the LFD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None